Fool.com contributor Parkev Tatevosian reviews Pfizer (PFE +0.60%) stock for passive income investors.
*Stock prices used were the afternoon prices of May 28, 2024. The video was published on May 30, 2024.
Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
By Parkev Tatevosian, CFA – May 31, 2024 at 3:30AM EST
NYSE: PFE
Pfizer
Market Cap
$143B
Today's Change
(0.60%) $0.15
Current Price
$25.19
Price as of December 19, 2025 at 4:00 PM ET
Pfizer's dividend yield is rising as the stock price is falling.
Read Next
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Stocks Mentioned
Pfizer
NYSE: PFE
$25.19 (+0.01%) $+0.15
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Advertisement